Low-dose MDMA ('ecstasy') induces vasopressin secretion

Lancet

Volumn 351, Issue 9118, 1998, Pages 1784-

  Henry, John A ^a   Fallon, John K ^b   Kicman, Andrew T ^b   Hutt, Andrew J ^b   Cowan, David A ^b   Forsling, Mary ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SODIUM; VASOPRESSIN;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HYPONATREMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

EID: 0032513972     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78744-4     Document Type: Article

References (5)

1. 1 Maxwell DL, Polkey MI, Henry JA. Hyponatraemia and catatonic stupor after taking "ecstasy". BMJ 1993; 307: 1399.
2. 2 Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA). Lancet 1996; 347: 1052.
3. 3 Forsling ML. Measurement of vasopressin in body fluids. In: Baylis PH, Padfield PL, eds. The posterior pituitary: hormone secretion in health and disease. New York: Marcel Dekker, 1985: 161-92.
4. 4 Fabian M, Forsling ML, Jones JJ, Pryor JS. The clearance and antidiuretic potency of neurohypophysial hormones in man and their plasma binding and stability. J Physiol 1969; 204: 653-68.
5. 5 Iovino M, Steardo L. Effects of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur J Pharmacol 1985; 113: 99-103.